Capsugel
Capsugel is set to more than double the size of its facility in Edinburgh, Scotland, enabling the company to meet rising customer demand for its liquid- and semi-solid-fill hard capsule development and manufacturing services.
The expansion will enable Capsugel’s Dosage Form Solutions business unit to both increase its capacity for products containing high-potency active pharmaceutical ingredients (HPAPIs) and further diversify its technology platforms.
The first phase of the expansion will include new analytical, formulation and quality laboratories designed to address customers’ bioavailability, HPAPI and other formulation challenges. The second phase will significantly expand commercial manufacturing capacity for the site’s existing technologies and bring the company’s other formulation and development technologies, including spray dried dispersion (SDD), to this location.
Amit Patel, president of Capsugel Dosage Form Solutions, said: “Capsugel’s breadth of technologies enables us, at the earliest stages of product development, to match the best technology to our customer’s specific needs, which can accelerate the timeline from discovery to launch.
"This investment furthers our strategy of taking the specific science and engineering know-how available at our individual locations and making it more accessible to customers throughout our global network.”